News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
Florian Lordick: Very honoured to receive the DGHO best abstract award 2023 for the Eortc1708 Vestige study
Photo taken from Florian Lordick/LinkedIn
Oct 18, 2023, 16:24

Florian Lordick: Very honoured to receive the DGHO best abstract award 2023 for the Eortc1708 Vestige study

Florian Lordick, Professor of Medicine at University of Leipzig, shared on LinkedIn:

“Very honoured to receive the DGHO (German Society for Hematology and Oncology) best abstract award 2023 for the Eortc1708 Vestige study.”

Source: Florian Lordick/LinkedIn

cancer DGHO Eortc1708 Vestige study Florian Lordick OncoDaily Oncology University of Leipzig
Special Coverage
Insight
Aug 31, 2024, 12:58
Eric Singhi: Our editorial in ASCO Daily News on the CHOICE-01 study
Blog
Aug 31, 2024, 12:55
Simple steps you can follow to reduce your cancer risk at any age by Arif Kamal - ACS
Insight
Aug 31, 2024, 12:49
New Insights on Psilocybin's Impact on the Human Brain by Joshua Siegel et al.
Blog
Aug 31, 2024, 12:46
Honoring Steve Abbott, Executive Director of Cincinnati Cancer Advisors
Blog
Aug 31, 2024, 11:09
Edward D. Esplin: Clinician Responses to Germline Genetic Testing in Prostate Cancer Management
Blog
Aug 31, 2024, 10:53
OncoInfluencers to Follow on Social Media: Dr. Fabio Ynoe de Moraes
Insight
Aug 31, 2024, 10:03
Myeloma Paper of the Day, August 31st, suggested by Robert Orlowski
Insight
Aug 31, 2024, 09:52
Article of the day, August 31st, suggested by the Immune Oncology Research Institute
Blog
Aug 31, 2024, 09:47
Christian Rolfo: Excellent educational experience at Swiss Oncology Summer School
Insight
Aug 31, 2024, 09:45
Piotr Wysocki: Older patients with mCRC receiving fluoropyrimidine+bevacizumab do not gain additional benefit from adding oxaliplatin
Blog
Aug 31, 2024, 09:41
Miriam Mutebi: Children's lives cut short by cancer is a tragedy we can't ignore
Insight
Aug 31, 2024, 09:08
Vivek Subbiah: Our commentary on Precision oncology across the ages